HIND — Vyome Holdings Share News
0.000.00%
Last trade - 00:00- $12.56m
- $5.94m
- $0.32m
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity
Brief: Livechain Completes Acquisition Of Senior, Secured Debt Of Humanyze
1953 Program Over The Next 6 Months
1953 Funding Requirements For Initial Phase 3 Results
NASDAQ RESUMED AT 10:14 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:09 AM
NASDAQ RESUMED AT 10:08 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:58 AM
1953 Plans To Advance Into Pivotal Study For FDA Approval
Brief: Vyome Holdings Files Prospectus Related To Resale Of 610,185 Shares Of Common Stock By Selling Stockholders
Brief: Vyome Holdings Acquires MIT AI Spinout Oculo Health
Brief: Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies
1953 In Malignant Fungating Wounds
Brief: Vyome Signs MoU With Embryyo, India’S Leading Medical Device Innovation Studio
Brief: Vyome Enters Amendment No. 1 To Equity Distribution Agreement
Brief: Reshape Lifesciences® Regains Compliance With Nasdaq Minimum Stockholders Equity Requirement